Outset Medical (OM) Equity Average (2019 - 2026)

Outset Medical (OM) has 8 years of Equity Average data on file, last reported at $119.3 million in Q1 2026.

• Equity Average for Q1 2026 came in at $119.3 million, up 21.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $119.3 million (up 21.33% YoY), and the FY2025 annual result was $76.9 million, up 2.72% from the prior year.
• Equity Average eased to $119.3 million in Q1 2026 per OM's latest filing, from $134.7 million in the prior quarter.
• Over five years, Equity Average peaked at $359.8 million in Q1 2022 and troughed at $37.3 million in Q4 2024.
• A 5-year average of $172.2 million and a median of $148.6 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2025: Equity Average tumbled 72.85% in 2024, then jumped 260.82% in 2025.
• A 5-year view of Equity Average shows it stood at $262.5 million in 2022, then sank by 47.64% to $137.5 million in 2023, then plunged by 72.85% to $37.3 million in 2024, then jumped by 260.82% to $134.7 million in 2025, then decreased by 11.39% to $119.3 million in 2026.
• Business Quant data shows OM's Equity Average at $119.3 million in Q1 2026, $134.7 million in Q4 2025, and $148.6 million in Q3 2025.